Moreover, it was found that these compounds had significant effects on the expression of apoptosis genes such as P53, P21 and Mcl-1. Accordingly, we suggest that these phenolic compounds are probable candidates for more research in animal models of breast cancer, as therapeutic agents, and adjuvants to standard chemotherapeutic drugs. This evidence concerns the gene TP53 and breast cancer.